JP2023534974A5 - - Google Patents

Info

Publication number
JP2023534974A5
JP2023534974A5 JP2023503413A JP2023503413A JP2023534974A5 JP 2023534974 A5 JP2023534974 A5 JP 2023534974A5 JP 2023503413 A JP2023503413 A JP 2023503413A JP 2023503413 A JP2023503413 A JP 2023503413A JP 2023534974 A5 JP2023534974 A5 JP 2023534974A5
Authority
JP
Japan
Prior art keywords
membered
compound according
alkyl
heteroaryl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023503413A
Other languages
English (en)
Japanese (ja)
Other versions
JP7793595B2 (ja
JP2023534974A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/042198 external-priority patent/WO2022020244A1/en
Publication of JP2023534974A publication Critical patent/JP2023534974A/ja
Publication of JP2023534974A5 publication Critical patent/JP2023534974A5/ja
Application granted granted Critical
Publication of JP7793595B2 publication Critical patent/JP7793595B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023503413A 2020-07-20 2021-07-19 補体因子の阻害剤及びその使用 Active JP7793595B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063054064P 2020-07-20 2020-07-20
US63/054,064 2020-07-20
PCT/US2021/042198 WO2022020244A1 (en) 2020-07-20 2021-07-19 Inhibitors of complement factors and uses thereof

Publications (3)

Publication Number Publication Date
JP2023534974A JP2023534974A (ja) 2023-08-15
JP2023534974A5 true JP2023534974A5 (https=) 2024-07-26
JP7793595B2 JP7793595B2 (ja) 2026-01-05

Family

ID=79729495

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023503413A Active JP7793595B2 (ja) 2020-07-20 2021-07-19 補体因子の阻害剤及びその使用

Country Status (18)

Country Link
US (3) US11814404B2 (https=)
EP (1) EP4185592A4 (https=)
JP (1) JP7793595B2 (https=)
KR (1) KR20230041758A (https=)
CN (2) CN116947903A (https=)
AR (1) AR123011A1 (https=)
AU (1) AU2021311455A1 (https=)
BR (1) BR112023001007A2 (https=)
CA (1) CA3186022A1 (https=)
CL (1) CL2023000191A1 (https=)
CO (1) CO2023000683A2 (https=)
IL (1) IL299840A (https=)
MX (1) MX2023000919A (https=)
PE (1) PE20231435A1 (https=)
PH (1) PH12023550153A1 (https=)
TW (1) TW202216168A (https=)
UY (1) UY39331A (https=)
WO (1) WO2022020244A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022020244A1 (en) 2020-07-20 2022-01-27 Annexon, Inc. Inhibitors of complement factors and uses thereof
IL314164A (en) 2022-01-14 2024-09-01 Annexon Inc Inhibitors of complement factors and their uses
AR131723A1 (es) * 2023-01-30 2025-04-23 5Metis Inc Compuestos que contienen boro y sus usos
WO2024254704A1 (en) * 2023-06-15 2024-12-19 The Governors Of The University Of Alberta Hemiboronic heterocyclic compounds and uses thereof
EP4553080A1 (en) 2023-11-07 2025-05-14 Ustav Organicke Chemie a Biochemie AV CR, v.v.i. Nucleoside derivatives as antiviral agents against coronaviruses

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965583A (en) 1997-04-24 1999-10-12 Ortho-Mcneil Pharmaceutical, Inc. Substituted imidazoles useful in the treatment of inflammatory disease
EP1971664B1 (en) * 2006-01-13 2015-09-09 LG Chem, Ltd. Emitting materials and organic light emitting device using the same
KR20100031723A (ko) 2007-07-07 2010-03-24 이데미쓰 고산 가부시키가이샤 크리센 유도체 및 이를 이용한 유기 전계 발광 소자
KR101233377B1 (ko) 2008-12-30 2013-02-18 제일모직주식회사 신규한 유기광전소자용 화합물 및 이를 포함하는 유기광전소자
WO2013049332A1 (en) * 2011-09-29 2013-04-04 Infinity Pharmaceuticals, Inc. Inhibitors of monoacylglycerol lipase and methods of their use
WO2015003146A1 (en) * 2013-07-03 2015-01-08 Georgetown University Boronic acid derivatives of resveratrol for activating deacetylase enzymes
DK3019240T3 (da) 2013-07-09 2024-06-03 Annexon Inc Anti-komplementfaktor C1Q antistoffer og anvendelser deraf
TWI532741B (zh) 2013-09-04 2016-05-11 喜星素材股份有限公司 含吡唑之多環化合物及使用其之有機發光裝置
KR101635154B1 (ko) 2014-08-28 2016-06-30 (주)더블유에스 피리딜기가 결합된 트리아진 유도체 및 이를 포함한 유기 전계발광 소자
KR102233296B1 (ko) * 2014-11-18 2021-03-29 덕산네오룩스 주식회사 유기전기 소자용 화합물, 이를 이용한 유기전기소자 및 그 전자 장치
AR103397A1 (es) * 2015-01-13 2017-05-10 Syngenta Participations Ag Oxoborazoles microbicidas
US10111885B2 (en) * 2015-03-13 2018-10-30 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases
KR101981245B1 (ko) 2015-10-27 2019-05-22 주식회사 엘지화학 고리 화합물 및 이를 포함하는 유기 발광 소자
KR101806464B1 (ko) 2015-11-19 2017-12-07 (주)랩토 피리딜기가 결합된 피리미딘 유도체 및 이를 이용한 유기 전계 발광 소자
KR102496411B1 (ko) 2016-01-06 2023-02-06 덕산네오룩스 주식회사 유기전기 소자용 화합물, 이를 이용한 유기전기소자 및 그 전자 장치
US10646488B2 (en) 2016-07-13 2020-05-12 Araxes Pharma Llc Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof
WO2019240471A1 (ko) 2018-06-11 2019-12-19 주식회사 엘지화학 헤테로고리 화합물 및 이를 포함하는 유기 발광 소자
WO2020032428A1 (ko) * 2018-08-09 2020-02-13 덕산네오룩스 주식회사 유기전기 소자용 화합물을 포함하는 유기전기소자 및 그 전자 장치
CN109574917B (zh) 2018-12-03 2020-12-08 武汉尚赛光电科技有限公司 一种芴酮衍生物及其制备和应用
CN109574910B (zh) * 2018-12-19 2021-07-02 山西大学 一种咔唑衍生物mcab及其制备方法和应用
CN111087387B (zh) 2019-12-26 2022-04-29 厦门天马微电子有限公司 一种有机化合物、显示面板及显示装置
CN111423390A (zh) 2020-03-30 2020-07-17 北京燕化集联光电技术有限公司 一种新型结构化合物及其应用
CN111662309B (zh) 2020-07-10 2021-11-09 北京燕化集联光电技术有限公司 一种多杂环结构化合物及其应用
WO2022020244A1 (en) 2020-07-20 2022-01-27 Annexon, Inc. Inhibitors of complement factors and uses thereof
CN113045585A (zh) 2021-03-16 2021-06-29 吉林奥来德光电材料股份有限公司 一种有机稠环化合物及其制备方法和应用
CN113831332B (zh) 2021-10-29 2024-06-18 长春海谱润斯科技股份有限公司 一种含氮杂环衍生物及其在有机电致发光器件中的应用
IL314164A (en) 2022-01-14 2024-09-01 Annexon Inc Inhibitors of complement factors and their uses

Similar Documents

Publication Publication Date Title
JP2023534974A5 (https=)
JP2024541929A5 (https=)
FI3215527T3 (fi) Humanisoituja anti-komplementtitekijä c1q -vasta-aineita ja niiden käyttöjä
JP2025504859A5 (https=)
JP2024521878A5 (https=)
JP2020518581A5 (https=)
JP2018509438A5 (https=)
MX2010013058A (es) Derivado de benceno o tiofeno y su uso como inhibidor de proteina 1 de adhesion vascular.
US20120172384A1 (en) Heterocyclylaminopyrimidines as kinase inhibitors
JP2015515976A5 (https=)
JP2018531982A5 (https=)
JP7359782B2 (ja) ブルトン型チロシンキナーゼに対する阻害剤
JP2016519680A5 (https=)
PL188077B1 (pl) Podstawione 1-fenylopirazolo-3-karboksyamidy jakosubstancje aktywne wobec receptorów neurotensyny,ich wytwarzanie i zawierające je kompozycje farmaceutyczne
JP7340023B2 (ja) テトラゾロン置換ステロイド及びその使用
TW200418799A (en) Phenyl or heteroaryl amino alkane derivatives
JP2022524243A5 (https=)
JP2013542267A5 (https=)
JP2021521178A5 (https=)
JP5781093B2 (ja) 新たな置換イソキノリン誘導体
JP2025502254A5 (https=)
JP2024506530A5 (https=)
AU2001246577B2 (en) Pyridazinyl phenyl hydrazones useful against congestive heart failure
CN105399737A (zh) 噁唑烷酮类化合物及其用途
JPWO2002057237A1 (ja) 置換アミノ基を有するヘテロ3環化合物